Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) have earned an average rating of “Moderate Buy” from the eleven analysts that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $11.88.

A number of research analysts have issued reports on ALHC shares. UBS Group boosted their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. Stephens reissued an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a report on Thursday, January 2nd. Stifel Nicolaus upped their target price on Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Tuesday, January 14th. Finally, Barclays upped their target price on Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 30th.

Alignment Healthcare Trading Down 8.4 %

Shares of NASDAQ:ALHC opened at $13.17 on Tuesday. Alignment Healthcare has a 12-month low of $4.46 and a 12-month high of $15.82. The company has a market capitalization of $2.52 billion, a PE ratio of -17.10 and a beta of 1.50. The business has a 50 day moving average of $13.19 and a two-hundred day moving average of $11.78. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, COO Sebastian Burzacchi sold 8,550 shares of the stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $11.26, for a total value of $96,273.00. Following the sale, the chief operating officer now owns 217,395 shares of the company’s stock, valued at $2,447,867.70. This trade represents a 3.78 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Hakan Kardes sold 10,500 shares of the stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $14.99, for a total value of $157,395.00. Following the completion of the sale, the insider now directly owns 309,944 shares in the company, valued at $4,646,060.56. This represents a 3.28 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 476,002 shares of company stock worth $6,220,726 in the last three months. 6.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. R Squared Ltd acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth about $55,000. nVerses Capital LLC purchased a new position in Alignment Healthcare during the 3rd quarter worth approximately $95,000. RiverPark Advisors LLC purchased a new position in Alignment Healthcare during the 4th quarter worth approximately $106,000. Tower Research Capital LLC TRC grew its stake in Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after buying an additional 6,286 shares during the last quarter. Finally, Ballentine Partners LLC purchased a new position in Alignment Healthcare during the 4th quarter worth approximately $121,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.